Figure 7
Schematic model for the hypocholesterolemica action of PD. PD enhances LDL-C uptake via increasing hepatic LDLR protein stability through inhibiting LXR-IDOL pathway. Furthermore, co-treatment of PD with simvastatin enhances their cholesterol-lowering effect.
